Page last updated: 2024-08-26

nicotine and 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate

nicotine has been researched along with 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grilli, M; Marchi, M; Parodi, M; Patti, L; Raiteri, L; Raiteri, M1
Kim, SU; Kim, SY; Lee, HG; Lee, YB; Moon, JH1
Atanasova, S; Bauer, S; Fronius, M; Grau, V; Hecker, A; Janciauskiene, S; Kaufmann, A; Klein, J; Küllmar, M; Kummer, W; Lerner, S; Lochnit, G; Mathes, V; Padberg, W; Richter, K; Schweda, EK; Timm, T; Wilker, S; Zakrzewicz, A1

Other Studies

3 other study(ies) available for nicotine and 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate

ArticleYear
P2X(7) receptors exert a permissive role on the activation of release-enhancing presynaptic alpha7 nicotinic receptors co-existing on rat neocortex glutamatergic terminals.
    Neuropharmacology, 2006, Volume: 50, Issue:6

    Topics: Adenosine Triphosphate; alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Aspartic Acid; Bridged Bicyclo Compounds, Heterocyclic; Bungarotoxins; Choline; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Electrochemistry; Enzyme Activation; Glutamic Acid; In Vitro Techniques; Magnesium; Male; Neocortex; Nicotine; Nicotinic Agonists; Presynaptic Terminals; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Time Factors; Tritium

2006
Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar beta amyloid peptide (1-42)-stimulated microglia.
    Experimental & molecular medicine, 2008, Feb-29, Volume: 40, Issue:1

    Topics: Adenosine Triphosphate; Amyloid; Amyloid beta-Peptides; Animals; Calcium; Enzyme Activation; Microglia; NADPH Oxidases; Nicotine; Nicotinic Antagonists; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Nicotinic; Receptors, Purinergic P2; Receptors, Purinergic P2X7

2008
Phosphocholine-Modified Macromolecules and Canonical Nicotinic Agonists Inhibit ATP-Induced IL-1β Release.
    Journal of immunology (Baltimore, Md. : 1950), 2015, Sep-01, Volume: 195, Issue:5

    Topics: Acetylcholine; Adenosine Triphosphate; alpha7 Nicotinic Acetylcholine Receptor; Animals; Blotting, Western; Cells, Cultured; Choline; Dose-Response Relationship, Drug; Humans; Interleukin-1beta; Lipopolysaccharides; Membrane Potentials; Monocytes; Nicotine; Nicotinic Agonists; Phosphorylcholine; Rats; Receptors, Nicotinic; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; U937 Cells

2015